SCHEMBL7606205

SCHEMBL7606205

CC(CP(=O)(O)Cc1ccccc1)(C(=O)O)c1cccnc1.CC(CP(=O)(O)Cc1ccccc1)(C(=O)O)c1ccncc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FDPS P14324 6/20 0.43
KCNA5 P22460 1/20 0.42
GPR132 Q9UNW8 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
BTN3A1 O00481 1/20 0.39
PDE3A Q14432 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
USP2 O75604 1/20 0.38
NAPRT Q6XQN6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7612297 0.95 FDPS (0.47) FDPSKCNA5GPR132CYP1A2CYP3A4
SCHEMBL7610487 0.92 ALPL (0.40) FDPSCYP3A4ALDH1A1MAPTHTT
SCHEMBL7610481 0.80 FDPS (0.44) FDPSKCNA5GPR132CYP1A2CYP3A4
SCHEMBL7603936 0.78 FDPS (0.43) FDPSKCNA5GPR132CYP1A2CYP3A4
SCHEMBL7609429 0.75 FDPS (0.46) FDPSKCNA5GPR132CYP1A2CYP3A4
SCHEMBL7605187 0.74 FDPS (0.45) FDPSKCNA5GPR132CYP1A2CYP3A4
SCHEMBL5497372 0.73 KCNA5 (0.48) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7607667 0.73 LMNA (0.40) LMNAHTT
SCHEMBL6178344 0.72 CYP1A2 (0.51) KCNA5CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7607525 0.72 MMP1 (0.37) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed